{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:34:28Z","timestamp":1763037268150,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10096-019-03496-0","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T07:57:59Z","timestamp":1549007879000},"page":"895-901","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Amoxicillin\/clavulanic acid+aminoglycoside as empirical antibiotic treatment in severe community-acquired infections with diagnostic uncertainty"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0445-5104","authenticated-orcid":false,"given":"Johan","family":"Courjon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Chirio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Demonchy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Michelangeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Degand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Marie","family":"Roger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"key":"3496_CR1","doi-asserted-by":"publisher","unstructured":"Aillet C, Jammes D, Fribourg A, L\u00e9otard S, Pellat O, Etienne P, et al (2018) Bacteraemia in emergency departments: effective antibiotic reassessment is associated with a better outcome. Eur J Clin Microbiol Infect Dis 37:325\u201331. \n                    https:\/\/doi.org\/10.1007\/s10096-017-3136-z","DOI":"10.1007\/s10096-017-3136-z"},{"key":"3496_CR2","doi-asserted-by":"publisher","unstructured":"Roger P-M, Demonchy E, Risso K, Courjon J, Leroux S, Leroux E, et al (2017) Medical table: A major tool for antimicrobial stewardship policy. Med Mal Infect 47:311\u20138. \n                    https:\/\/doi.org\/10.1016\/j.medmal.2017.03.005","DOI":"10.1016\/j.medmal.2017.03.005"},{"key":"3496_CR3","doi-asserted-by":"crossref","unstructured":"Denis E, Martis N, Guillouet-de-Salvador F (2016) Bacteraemic urinary tract infections may mimic respiratory infections: a nested case-control study. Eur J Clin Microbiol Infect Dis 1601\u20131605","DOI":"10.1007\/s10096-016-2697-6"},{"key":"3496_CR4","doi-asserted-by":"crossref","unstructured":"Gavazzi G, Krause K-H (2002) Ageing and infection. Lancet Infect Dis 2:659\u2013666","DOI":"10.1016\/S1473-3099(02)00437-1"},{"key":"3496_CR5","doi-asserted-by":"crossref","unstructured":"Filice AG, Drekonja DM, Thurn H JR, GM M, T J JR (2015) Diagnostic errors that lead to inappropriate antimicrobial use. Infect Control Hosp Epidemiol 949\u2013956","DOI":"10.1017\/ice.2015.113"},{"key":"3496_CR6","doi-asserted-by":"publisher","unstructured":"Roca I, Akova M, Baquero F, Carlet J, Cavaleri M, Coenen S, et al (2015) The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect 6:22\u20139. \n                    https:\/\/doi.org\/10.1016\/j.nmni.2015.02.007","DOI":"10.1016\/j.nmni.2015.02.007"},{"key":"3496_CR7","doi-asserted-by":"publisher","unstructured":"Sartelli M, Malangoni MA, May AK, Viale P, Kao LS, Catena F, et al (2014) World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections. World J Emerg Surg 9:57. \n                    https:\/\/doi.org\/10.1186\/1749-7922-9-57","DOI":"10.1186\/1749-7922-9-57"},{"key":"3496_CR8","doi-asserted-by":"publisher","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al (2016) Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 62:e51-77. \n                    https:\/\/doi.org\/10.1093\/cid\/ciw118","DOI":"10.1093\/cid\/ciw118"},{"key":"3496_CR9","doi-asserted-by":"publisher","unstructured":"Zahar J-R, Lesprit P, Ruckly S, Eden A, Hikombo H, Bernard L, et al (2017) Predominance of healthcareassociated cases among episodes of community-onset bacteraemia due to extended-spectrum \u00df-lactamase-producing Enterobacteriaceae. Int J Antimicrob Agents 49:67\u201373. \n                    https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.09.032","DOI":"10.1016\/j.ijantimicag.2016.09.032"},{"key":"3496_CR10","doi-asserted-by":"publisher","unstructured":"Rogers BA, Sidjabat HE, Paterson DL (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66:1\u201314. \n                    https:\/\/doi.org\/10.1093\/jac\/dkq415","DOI":"10.1093\/jac\/dkq415"},{"key":"3496_CR11","doi-asserted-by":"publisher","unstructured":"Vazquez-Grande G, Kumar A (2015) Optimizing antimicrobial therapy of sepsis and septic shock: focus on antibiotic combination therapy. Semin Respir Crit Care Med 36:154\u201366. \n                    https:\/\/doi.org\/10.1055\/s-0034-1398742","DOI":"10.1055\/s-0034-1398742"},{"key":"3496_CR12","doi-asserted-by":"crossref","unstructured":"Vall\u00e9s J, Rello J, Ochagav\u00eda A, Garnacho J, Alcal\u00e1 MA (2003) Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 123:1615\u201324","DOI":"10.1378\/chest.123.5.1615"},{"key":"3496_CR13","doi-asserted-by":"publisher","unstructured":"Marchaim D, Zaidenstein R, Lazarovitch T, Karpuch Y, Ziv T, Weinsberger M (2008) Epidemiology of bacteremia episodes in a single center: increase in gram-negative isolates, antibiotics resistance and patient age. Eur J Mircobiol Infect Dis 27(11):1045\u201351. \n                    https:\/\/doi.org\/10.1007\/s10096-008-0545-z","DOI":"10.1007\/s10096-008-0545-z"},{"key":"3496_CR14","doi-asserted-by":"publisher","unstructured":"Spivak ES, Cosgrove SE, Srinivasan A (2016) Measuring Appropriate Antimicrobial Use: Attempts at Opening the Black Box. Clin Infect Dis 63:1639\u201344. \n                    https:\/\/doi.org\/10.1093\/cid\/ciw658","DOI":"10.1093\/cid\/ciw658"},{"key":"3496_CR15","doi-asserted-by":"crossref","unstructured":"Braykov N, Morgan DJ, Schweizer. ML et al (2014) Assessment of empirical therapy in six hospitals: an observational cohort study. Lancet Infect Dis 1220\u20137","DOI":"10.1016\/S1473-3099(14)70952-1"},{"key":"3496_CR16","doi-asserted-by":"publisher","unstructured":"Shallcross LJ, Freemantle N, Nisar S, Ray D (2016) A cross-sectional study of blood cultures and antibiotic use in patients admitted from the Emergency Department: missed opportunities for antimicrobial stewardship BMC Infect Dis 16:166. \n                    https:\/\/doi.org\/10.1186\/s12879-016-1515-1","DOI":"10.1186\/s12879-016-1515-1"},{"key":"3496_CR17","doi-asserted-by":"crossref","unstructured":"Winokur PL, Canton R. Casellas JM, Legakis N. (2001) Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 32(Suppl 2):s94\u2013103","DOI":"10.1086\/320182"},{"key":"3496_CR18","doi-asserted-by":"publisher","unstructured":"Russo A, Falcone M, Guti\u00e9rrez-Guti\u00e9rrez B, Calbo E, Almirante B, Viale PL, et al (2018) Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum \u00df-lactamase-producing Enterobacteriaceae. Int J Antimicrob Agents 52:577\u201385. \n                    https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.06.018","DOI":"10.1016\/j.ijantimicag.2018.06.018"},{"key":"3496_CR19","doi-asserted-by":"publisher","unstructured":"Lefort A, Panhard X, Clermont O, Woerther P-L, Branger C, Mentr\u00e9 F, et al (2011) Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia. J Clin Microbiol 49:777\u2013783. \n                    https:\/\/doi.org\/10.1128\/JCM.01902-10","DOI":"10.1128\/JCM.01902-10"},{"key":"3496_CR20","doi-asserted-by":"publisher","unstructured":"Courjon J, Demonchy E, Degand N, Risso K, Ruimy R, Roger P-M (2017) Patients with community-acquired bacteremia of unknown origin: clinical characteristics and usefulness of microbiological results for therapeutic issues: a single-center cohort study. Ann Clin Microbiol Antimicrob 16:40. \n                    https:\/\/doi.org\/10.1186\/s12941-017-0214-0","DOI":"10.1186\/s12941-017-0214-0"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03496-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03496-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03496-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T18:08:53Z","timestamp":1555351733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03496-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["3496"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03496-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2019,2,1]]},"assertion":[{"value":"23 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All of the authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The antibiotic audit was sponsored by the French National Health Agency. The patients or their relatives provided written consent for computerization of their personal data for hospitalization purposes and clinical research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}